Jaywin Remedies Profile
Key Indicators
- Authorised Capital ₹ 3.50 M
as on 02-07-2024
- Paid Up Capital ₹ 3.50 M
as on 02-07-2024
- Company Age 36 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 20.87 Cr
as on 02-07-2024
- Satisfied Charges ₹ 14.23 Cr
as on 02-07-2024
- Revenue 15.02%
(FY 2022)
- Profit -14.94%
(FY 2022)
- Ebitda -4.10%
(FY 2022)
- Net Worth 33.82%
(FY 2022)
- Total Assets 4.15%
(FY 2022)
About Jaywin Remedies
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 M and a paid-up capital of Rs 3.50 M.
The company currently has active open charges totaling ₹20.87 Cr. The company has closed loans amounting to ₹14.23 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vivek Batra, Ajay Joshi, and Shibu Kurup serve as directors at the Company.
- CIN/LLPIN
U24231GJ1988PTC010605
- Company No.
010605
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Apr 1988
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Jaywin Remedies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shibu Kurup  | Director | 13-Feb-2007 | Current |
| Vivek Batra | Director | 03-Jul-2023 | Current |
| Ajay Joshi | Director | 13-Feb-2007 | Current |
Financial Performance and Corporate Structure Insights of Jaywin Remedies.
Jaywin Remedies Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 15.02% increase. The company also saw a substantial fall in profitability, with a 14.94% decrease in profit. The company's net worth Soared by an impressive increase of 33.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jaywin Remedies?
In 2022, Jaywin Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Prism Life Sciences LimitedActive 22 years 3 monthsVivek Batra, Ajay Joshi and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Mar 2024 | ₹4.27 Cr | Open |
Others Creation Date: 24 Jan 2024 | ₹7.50 Cr | Open |
Yes Bank Limited Creation Date: 29 Jul 2023 | ₹7.10 Cr | Open |
How Many Employees Work at Jaywin Remedies?
Jaywin Remedies has a workforce of 87 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jaywin Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jaywin Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
